Cell transdifferentiation specialist Mogri... British start-up company Mogrify Ltd (Cambridge, UK) has added US$16m from a Series A round to its US$3.7m seed financing in February 2019. Existing investor Ahren Innovation Capital led the round, … more ➔
Patient’s organoids predict response... A new test based on tumour organoids can predict how patients with advanced colorectal cancer respond to chemotherapy treatment. more ➔
ADC Therapeutics enters licence option dea...ADC Therapeutics SA has entered a R&D pact with Affimer developer Avacta Group plc aimed at creating and licencing Affimer drug conjugates. more ➔
Novo Nordisk enters haemophilia gene thera...Licencing bluebird bios Inc know-how and technology in one-time gene therapies, Novo Nordisk A/S tries to get a foothold in the emerging haemophilia A gene therapy market. more ➔
Evotec and Celmatix enter strategic partne... Evotec SE has expanded its drug discovery customer base with US women’s health specialist Celmatix Inc. more ➔
Qiagen/Illumina: Earthquake in NGS IVD mar...QIAGEN and Illumina join forces in the next-gen sequencing-based IVD testing and companion diagnostics market announcing a 15-year collaboration. more ➔
Researchers unravel how ADEP antibiotics w...German researchers have determined the mechanism of a ADEPs, a novel class of antibiotics, allowing for pharmacological optimisation. more ➔
New method allows tracking of HIVA new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose. more ➔
Successful EFIB in BrusselsHow can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels. more ➔
Rottapharm Biotech: POC in osteoarthritis...Rottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis. more ➔